网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
介入治疗前后宫颈癌患者局部组织及外周血中调节性T细胞的动态变化研究
作者:陈赛英  杨斌  朱启江  肖梅 
单位:中国人民解放军第八一医院 妇产科, 江苏 南京 210029
关键词:调节性T细胞 流式细胞术 宫颈癌 介入治疗 
分类号:R737.3;Q768
出版年·卷·期(页码):2018·46·第一期(31-33)
摘要:

目的:探讨宫颈癌患者介入治疗前后宫颈局部组织及外周血中调节性T细胞数量及其动态变化。方法:采用流式细胞术检测74例宫颈癌患者介入治疗前,介入治疗7、14 d后宫颈癌局部组织及外周血中调节性T淋巴细胞占CD4+T细胞的比率。结果:介入治疗7 d后宫颈癌局部组织及外周血中调节性T淋巴细胞均较介入治疗前降低,介入治疗14 d后宫颈癌局部组织及外周血中调节性T淋巴细胞回升至介入治疗前水平,差异均有统计学意义(P<0.01)。结论:宫颈癌的介入治疗在一定时间内可以有效地增强宫颈癌患者的抗肿瘤能力,提高机体免疫力。

Objective:To investigate the number and the dynamic changes of regulatory T cells in the local tissues and peripheral blood of the cervical cancer patients before and after interventional therapy. Methods:Flow cytometry was used to detect the ratio ofregulatory Tcells to CD4+T cells and the dynamic changes before and 7 days and 14 days after interventional therapy in patients with cervical cancer. Results:Seven days after interventional therapy, the local tissue and peripheral blood regulatory T cells were lower than those before intervention. Fourteen days after interventional therapy the local tissue and peripheral blood regulatory T cells rose up reachingto the levels before the intervention gradually,there was statistical significance (P<0.01). Conclusion:Interventional therapy can effectively enhance the anti-tumor ability and immunity of the patients with cervical cancer in a certain period of time.

参考文献:

[1] KIM S,LEE A,LIM W,et al.Zonal difference and prognostic significance of foxp3 regulatory T cell infiltration in breast cancer[J].J Breast Cancer,2014,17(1):8-17.
[2] 石嘉俪,周佳青. 甲状腺乳头状癌患者外周血CD4+CD25+调节性T细胞的检测及临床意义[J]. 临床耳鼻喉头颈外科杂志,2012,26(21)965-969,972.
[3] LIOTTA F,GACCI M,FROSALI F,et al.Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal carcinoma[J].BJU Int,2011,107(9):1500-1506.
[4] HANAGIRI T,SHIGEMATSU Y,SHINOHARA S,et al.Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer[J].Lung Cancer,2013,81(3):475-479.
[5] SAVAGE P A,MALCHOW S,LEVENTHAL D S.Basic principles of tumor-associated regulatory T cells biology[J].Trends Immunol,2013,34(1):33-40.
[6] HOU F,LI Z,MA D,et al.Distribution of Th17 cells and Foxp3-expressing with T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer[J].Clin Chim Acta,2012,413(23-24):1848-1854.
[7] 吴婧文,平波,杨文韬,等.宫颈癌及其前期患者外周血调节性T细胞的差异分析[J].中国癌症杂志,2013,23(3):167-172.
[8] 陈莉婷,陈春林,刘萍.介入治疗前后宫颈癌局部组织Fas/FasL系统动态变化[J].实用妇产科杂志,2006,22(8):472-474.
[9] 杨斌,陈赛英,史佃云,等.宫颈癌介入前后组织中Survivin、Caspase-3和Caspase-7的表达变化及意义[J].临床肿瘤学杂志,2009,14(14):39-42.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 238573 位访问者


 ©《现代医学》编辑部
联系电话:025-83272479;83272481
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541